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Jeffrey Brent1 and Mohammad Abdollahi2*The science of toxicology in all of its various aspects is,
of necessity, a global one. The production and release of
potentially toxic chemicals is increasing in many parts of
the world. While this can cause local environmental pro-
blems, chemical contamination does not respect inter-
national and political borders and the resulting health
concerns are shared by the global toxicology community.
The web-based World Library of Toxicology (www.
wltox.org), a collaborative effort between Toxipedia.org,
the US National Library of Medicine, the International
Union of Toxicology, and the Institute of Neurotoxicol-
ogy and Neurological disorders, was established because
of such global concerns. Its intent is to facilitate scien-
tific interchange among various countries. No longer
can toxicology function as a fragmented discipline, with
individual efforts largely isolated by international
borders.
While the concept of the internationalization of toxi-
cology can take the form of collaborative relationships
between individual scholars and researchers with over-
lapping interests, the true potential of such collabora-
tions can best be realized when larger institutions such
as governments or professional societies join forces. A
classic example of such a collaboration is when the
American Academy of Clinical Toxicology (AACT) and
the European Association of Poison Control Centres and
Clinical Toxicologists (EAPCCT) jointly generated a
series of scholarly position statements that resulted in a
major upheaval in the approaches to gastrointestinal de-
contamination in poisoned patients—an upheaval that is
still being felt in clinical practice today and one that
has enhanced the care of our patients. This collaboration
between societies, an important event in the history
of clinical toxicology, should serve not just as position
statements, but more importantly as an emblematic* Correspondence: mohammad@tums.ac.ir
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interact.
The patterns of international scientific collaboration
can be investigated by analyzing scientometric databases
for internationally co-authored articles. Such an investi-
gation shows that the science of toxicology is growing
globally. For example, when countries from different
regions of the world are searched in SCImago for their
scientific production in toxicology, then the top coun-
tries from 10 regions of the world are as follow: Iran
from Middle East, UK from Western Europe, Poland
from Eastern Europe, Tunisia from Northern Africa, Ni-
geria from Central Africa, South Africa from Southern
Africa, USA from Northern America, Brazil from Latin
America, China from Asiatic Region, and Australia from
Pacific region.
If the number of registered toxicologists from societies
of these countries from the IUTOX database are
counted, an estimated 4000 members are found. The ac-
tual number of toxicologists is undoubtedly much higher
since many societies are not part of IUTOX. Therefore if
only a limited network would be established between
those members in these regions of the world, the poten-
tial for collaborations on issues such as the care of the
poisoned patient, protection of pregnant women, chil-
dren, and other potentially vulnerable populations from
toxic harm in the environment, and better worker pro-
tection—all matters of the utmost importance to clinical
toxicology—would be great. This is particularly import-
ant in medically underserved areas such as many African
countries.
We believe that one of the roles of toxicology societies
is to follow the example set by the AACT and the
EAPCCT to enhance these collaborations. In doing so,
different skill sets, expertise and perspectives can be
combined to address high-level global challenges. There
are many ways societies can do this. The possibilities are
so vast that it is beyond the scope of this short call to
cooperation to list. Certainly the immediately obvious
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ities, the funding and promotion of international re-
search and travel grants, and joint policy statements and
practice guidelines about matters of major international
importance. Our professional societies can serve as the
catalysts and facilitators of these efforts by providing the
organizational infrastructure.
The case of the US and Iran provides a salient example
of the potential for this kind of collaboration. The chal-
lenges of travel between these countries for scientific
collaboration are daunting. Despite governmental obsta-
cles, the collaboration between US and Iranian scientists
has been steadily increasing. For example, the 2009 10th
Iranian Congress of Toxicology, a meeting with excellent
scientific content, had several US members on the scien-
tific committee, including one of the authors of this edi-
torial, all unable to attend the meeting because of
political issues unrelated to our discipline. The problem
of visas for Iranian toxicologists who wish to study,
train, and collaborate with colleagues in the US is im-
peding the natural non-political flow of scientific inter-
action between colleagues in our two countries. These
two societies, however, can go forward where govern-
ments cannot. For example, the AACT, an organization
with considerable international membership, is advertis-
ing the upcoming Irantox meeting on its website (www.
clintox.org). This gesture, although small in the geo-
political quandary of the barriers for collaboration be-
tween toxicologists in our two countries, can serve as an
example of a first step in a greater relationship between
international societies. The same thing exists for Iranian
Society of Toxicology (IranTox) that has kept the link of
AACT to keep members updated about science of toxi-
cology (www.irantox.ir). There is much to gain from
these interchanges. For example, the Iranian model of
the care of poisoned patients is oriented around a few
specialized treatment centers that see at least of an order
of magnitude more patients than the busiest medical
toxicology services in the US. This vast wealth of clinical
data provides an excellent opportunity for mutual re-
search. The US is one of the goal countries to which tal-
ented Iranian scientists and physicians are interested to
travel, in the hope that by doing so they may have the
potential to achieve better clinical and scientific posi-
tions [1].
The internet has provided an invaluable scientific tool
for international collaboration by globalizing access to
toxicology resources and allowing communication be-
tween colleagues irrespective of political boundaries.
Most interestingly, as reported by NewScientists [2] and
UK’s Royal Society [3], despite political tensions between
the USA and Iran, scientific collaboration has proven
surprisingly resilient. Between the periods 1996 to 2008,
co-authored papers between these two countriesincreased from just 388 papers to 1,831 [3]. Recent data
indicates that Iran’s scientific output rose 18-fold be-
tween 1996 and 2008, from only 736 published papers to
13,238 during this time interval, giving Iran has the fast-
est rate of increase in scientific publication in the world.
Among such growth of sciences, the toxicology is listed
among the top fields [4-6]. The comparison of drug and
poison information centers in Iran and USA is a good
example of similarities of scientific concerns between two
countries [7]. The enthusiasm for toxicology in Iran, the
vast scientific resources and opportunities in the US, and
the vibrant cooperation seen between toxicologists in two
countries, indicate that this is the time for the AACT and
the IranTox move beyond geo-political barriers to es-
tablish a more formal collaborative structure. In this res-
pect to increase mutual scientific collaboration between
IranTox and AACT, both societies in (January 10, 2012)
agreed to share common interests in the academic spe-
cialty of toxicology to increase their cooperation in edu-
cation and research in topics within clinical toxicology
wherever it may be deemed possible. They also decided
to promote international intellectual exchanges and the
scholarly pursuits of members within both organizations
in the future.
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